https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accounts-payable https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accounts-receivable https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accrued-liabilities-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/accumulated-depreciation https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/additional-paid-in-capital https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/assets-held-in-trust https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/assets-held-in-trust-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/basic-shares https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/capital https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/capital-expenditures https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cash https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cash-and-equivalents https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cash-flow-breakdown https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/common-stock-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cost-of-revenue https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/current-assets https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/current-liabilities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/debt-annual-principal-payment https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/debt-convertible-threshold-percentage-of-stock-price-trigger https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/debt-face-amount https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/debt-unamortized-discount https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-income-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-offering-costs https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-revenue https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-revenue-additions https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/depreciation https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/derivative-liabilities-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/diluted-shares https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/dilutive-shares https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/dividends-common-stock https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/due-to-related-parties-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/effective-tax-rate https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/eps https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/eps-basic https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/fair-value-liabilities-debt-valuation-techniques-change-in-technique-quantification-of-effect https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/federal-deposit-insurance-corporation-premium-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/financing-cash-flow https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/form-d-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/general-and-administrative-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/gross-profit https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/income-loss-from https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/income-tax https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/insider-transactions-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/insider-transactions-warrants https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/interest-and-dividend-income-securities-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/interest-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/interest-expense-on-debt https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/interest-expense-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/interest-expense-related-party https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/interest-paid-net https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/inventory https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/inventory-finished-goods https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/inventory-gross https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/inventory-raw-materials https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/inventory-work-in-process https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/investing-cash-flow https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/investment-income-interest https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/investment-income-interest-and-dividend https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/lease-cost https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/level-3-asset-transfers-net https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/litigation-settlement-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/long-term-debt-maturing-in-years-four-and-five https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/net-income https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/net-income-loss-including-portion-attributable-to-nonredeemable-noncontrolling-interest https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/notes-payable-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/notes-payable-related-parties-noncurrent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/operating-cash-flow https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/operating-expenses https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/operating-lease-payments-due https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/other-income https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/payments-of-financing-costs https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/payments-to-acquire-assets-investing-activities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-shares-facts https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/preferred-stock-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/prepaid-expense-current https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/prepaid-interest https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/pretax-income https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-issuance-of-senior-long-term-debt https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-loan-originations https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/professional-fees https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/profit-loss https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/property-plant-equipment https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/public-float https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/redeemable-noncontrolling-interest-equity-common-carrying-amount https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/redeemable-noncontrolling-interest-equity-preferred-carrying-amount https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/related-party-tax-expense-effect-of-change-in-allocation-methodology https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/research-and-development https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/retained-earnings https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/revenue https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/royalty-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/sale-leaseback-transaction-rent-expense https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/secured-debt https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/secured-debt-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/servicing-liability-at-fair-value-other-changes-in-fair-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/shareholders-equity https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/shares-authorized https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/shares-issued https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/shares-issued-2 https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/sponsor-fees https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-rsu-aggregate-intrinsic-value-outstanding https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-based-compensation https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tangible-capital https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/taxes-other https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/temporary-equity-aggregate-amount-of-redemption-requirement https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/total-assets https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/total-liabilities https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/clarus-therapeutics-holdings-inc/weighted-average-number-of-share-outstanding-basic-and-diluted